Unraveling the connection: Uveitis prevalence and risk factors in psoriasis patients — a population‐based study

Author:

Patt Yonatan Shneor12ORCID,Ben‐Shabat Niv12,Sharif Kassem123,David Paula12,Patt Chen14,Elizur Yoav12,Shani Uria12,Zacay Galia56,Watad Abdulla127ORCID,Amital Howard12

Affiliation:

1. Department of Internal Medicine B & Zabludowicz Center for Autoimmune Diseases Sheba Medical Center Tel‐Hashomer Israel

2. Sackler Faculty of Medicine Tel‐Aviv University Tel‐Aviv Israel

3. Department of Gastroenterology Sheba Medical Center Tel‐Hashomer Israel

4. The Adelson School of Medicine Ariel University Ariel Israel

5. Department of Family Medicine Meuhedet Health Maintenance Organization Tel Aviv Israel

6. Department of Family Medicine, Sackler Faculty of Medicine University of Tel Aviv Tel Aviv Israel

7. Section of Musculoskeletal Disease, NIHR Leeds Musculoskeletal Biomedical Research Unit Leeds Institute of Molecular Medicine, University of Leeds, Chapel Allerton Hospital Leeds UK

Abstract

AbstractThe association between uveitis and spondyloarthropathy (SpA)‐related conditions is well‐established. However, evidence describing the link between uveitis and psoriasis, and psoriasis without concomitant SpA‐related conditions is scarce and conflicting. This large‐scale population‐based study sought to describe the prevalence and features of uveitis among psoriasis patients in Israel as well as investigating the risk for uveitis in different subgroups of psoriasis patients compared to the general population. We conducted a retrospective study utilizing the electronic database of the Meuhedet Health Maintenance Organization. The study included all patients diagnosed with psoriasis between 2000 and 2020, each patient was matched with four controls based on age, sex, place of residence, and index date. Logistic regression models were employed to assess the association between psoriasis and uveitis while adjusting for the presence of SpA‐related conditions. A total of 61 003 psoriasis patients and 244 012 matched controls were included. The prevalence of uveitis was 1.3% versus 1.1% respectively (OR  1.12; 95% CI 1.10–1.30; p < 0.001). When adjusting to psoriasis severity, concurrent SpA, and psoriasis treatment no significant association was found. The rates of uveitis among psoriasis patients with concurrent SpA‐related conditions was 3.2% compared to 1.4% in controls without psoriasis or SpA (OR 2.38; 95% CI 2.00–2.83; p < 0.001), while in psoriasis patients without SpA, the rate of uveitis was 1.0% and was similar to controls. Although crude rates of uveitis were higher in patients with severe psoriasis compared to mild psoriasis (2.1% vs. 1.1%), after adjustment, no significant association compared to controls was found in either group. Our findings suggest that the positive association between psoriasis and uveitis is primarily mediated by the coexistence of other SpA‐related conditions. These findings imply the presence of a shared pathogenetic mechanism and set the direction for a phenotypic‐targeted screening strategy.

Funder

Janssen Pharmaceuticals

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3